Primary solitary fibrous tumor of the thyroid gland: A review starting from a case report
Abstract
##plugins.themes.bootstrap3.article.details##
solitary fibrous tumor, thyroid, mesenchymal neoplasm, CD34, BCL-2, STAT6
2. Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013; 45(2):131-132. https://doi.org/10.1038/ng.2522 .
3. Huang SC, Huang HY. Solitary fibrous tumor: An evolving and unifying entity with unsettled issues. Histol Histopathol. 2019; 34(4):313-334. https://doi.org/10.14670/HH-18-064 .
4. Klemperer P, Rabin CB. Primary neoplasms of the pleura. A report of five cases. Arch Pathol. 1931; 11:385-412.
5. Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014; 27(3):390-395. https://doi.org/10.1038/modpathol.2013.164.
6. Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013; 125(5):651-658. https://doi.org/10.1007/s00401-013-1117-6
7. Larsen SR, Godballe C, Krogdahl A. Solitary fibrous tumor arising in an intrathoracic goiter. Thyroid. 2010; 20(4):435-437. https://doi.org/10.1089/thy.2009.0237
8. Suh YJ, Park JH, Jeon JH, Bilegsaikhan SE. Extrapleural solitary fibrous tumor of the thyroid gland: A case report and review of literature. World J Clin Cases. 2020; 8(4):782-789. https://doi.org/10.12998/wjcc.v8.i4.782.
9. Mizuuchi Y, Yamamoto H, Nakamura K, et al. Solitary fibrous tumor of the thyroid gland. Med Mol Morphol. 2014; 47(2):117-122. https://doi.org/10.1007/s00795-013-0056-6
10. Taccagni G, Sambade C, Nesland J, Terreni MR, Sobrinho-Simões M. Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases. Virchows Arch A Pathol Anat Histopathol. 1993; 422(6):491-497. https://doi.org/10.1007/BF01606459
11. Mohamed A, Qureshi F, Eldin RS. Solitary fibrous thyroid tumor: A case report. J Endocr Soc. 2021; 5(1 Suppl):A900-901. https://doi.org/10.1210/jendso/bvab048.1838.
12. Papi G, Corrado S, Uberti ED, Roti E. Solitary fibrous tumor of the thyroid gland. Thyroid. 2007; 17(2):119-126. https://doi.org/10.1089/thy.2005.0202
13. Thompson LDR, Wei C, Rooper LM, Lau SK. Thyroid gland solitary fibrous tumor: report of 3 cases and a comprehensive review of the literature. Head Neck Pathol. 2019; 13(4):597-605. https://doi.org/10.1007/s12105-019-01012-6
14. Song Z, Yu C, Song X, Wei L, Liu A. Primary solitary fibrous tumor of the thyroid - report of a case and review of the literature. J Cancer. 2011; 2:206-209. https://doi.org/10.7150/jca.2.206
15. Saeed O, Zhang S, Cheng L, Lin J, Alruwaii F, Chen S. STAT6 expression in solitary fibrous tumor and histologic mimics: a single institution experience. Appl Immunohistochem Mol Morphol. 2020; 28(4):311-315. https://doi.org/10.1097/PAI.0000000000000745
16. Tariq MU, Din NU, Abdul-Ghafar J, Park YK. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. Diagn Pathol. 2021; 16(1):32. https://doi.org/10.1186/s13000-021-01095-2
17. Han Y, Zhang Q, Yu X, et al. Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas. Int J Clin Exp Pathol. 2015; 8(10):13166-13175. PMID:26722515.
18. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S, Hirose T, Sano T. Frequent expression of bcl-2 protein in solitary fibrous tumors. Jpn J Clin Oncol. 1998; 28(2):86-91. https://doi.org/10.1093/jjco/28.2.86
19. Geramizadeh B, Marzban M, Churg A. Role of immunohistochemistry in the diagnosis of solitary fibrous tumor, a review. Iran J Pathol. 2016; 11(3):195-203. PMID:27799967.
20. Mordenti P, Di Cicilia R, Delfanti R, Capelli P, Paties C, Cavanna L. Solitary fibrous tumors of the pleura: a case report and review of the literature. Tumori. 2013; 99(4):e177-183. https://doi.org/10.1700/1361.15120
21. Ronchi A, Cozzolino I, Zito Marino F, et al. Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features. Ann Diagn Pathol. 2018; 34:142-150. https://doi.org/10.1016/j.anndiagpath.2018.01.004
22. Kao YC, Lin PC, Yen SL, et al. Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumours: a comparative histological, immunohistochemical and molecular study of 36 cases. Histopathology. 2016; 68(4):492-501. https://doi.org/10.1111/his.12772
23. Kant R, Davis A, Verma V. Thyroid nodules: advances in evaluation and management. Am Fam Physician. 2020; 102(5):298-304. PMID:32866364
24. Ning S, Song X, Xiang L, Chen Y, Cheng Y, Chen H. Malignant solitary fibrous tumor of the thyroid gland: report of a case and review of the literature. Diagn Cytopathol. 2011; 39(9):694-699. https://doi.org/10.1002/dc.21538
25. Parwani AV, Galindo R, Steinberg DM, Zeiger MA, Westra WH, Ali SZ. Solitary fibrous tumor of the thyroid: cytopathologic findings and differential diagnosis. Diagn Cytopathol. 2003; 28(4):213-216. https://doi.org/10.1002/dc.10264
26. Tani E, Wejde J, Åström K, Wingmo IL, Larsson O, Haglund F. FNA cytology of solitary fibrous tumors and the diagnostic value of STAT6 immunocytochemistry. Cancer Cytopathol. 2018; 126(1):36-43. https://doi.org/10.1002/cncy.21923
27. Tanahashi J, Kashima K, Daa T, et al. Solitary fibrous tumor of the thyroid gland: report of two cases and review of the literature. Pathol Int. 2006; 56(8):471-477. https://doi.org/10.1111/j.1440-1827.2006.01992.x
28. Cameselle-Teijeiro J, Manuel Lopes J, Villanueva JP, Gil-Gil P, Sobrinho-Simões M. Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid. Histopathology. 2003; 43(4):406-408. https://doi.org/10.1046/j.1365-2559.2003.01696.x
29. Koelsche C, Schweizer L, Renner M, et al. Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology. 2014; 65(5):613-622. https://doi.org/10.1111/his.12431
30. Cameselle-Teijeiro J. Uncommon tumors of the thyroid gland. Int J Surg Pathol. 2010; 18(3 Suppl):S205-208. https://doi.org/10.1177/1066896910370885
31. Corrado S, Corsello SM, Maiorana A, et al. Papillary thyroid carcinoma with predominant spindle cell component: report of two rare cases and discussion on the differential diagnosis with other spindled thyroid neoplasm. Endocr Pathol. 2014; 25(3):307-314. https://doi.org/10.1007/s12022-013-9290-7
32. Takada N, Hirokawa M, Ito M, et al. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases. Endocr J. 2017; 64(10):1017-1023. https://doi.org/10.1507/endocrj.EJ17-0242
33. Folpe AL, Lloyd RV, Bacchi CE, Rosai J. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Am J Surg Pathol. 2009; 33(8):1179-1186. https://doi.org/10.1097/PAS.0b013e31819e61c8
34. Chen G, Liu Z, Su C, et al. Primary peripheral nerve sheath tumors of the thyroid gland: A case report and literature review. Mol Clin Oncol. 2016; 4(2):209-210. https://doi.org/10.3892/mco.2015.703
35. Zhang Y, Tang H, Hu H, Yong X. A rare primary tumor of the thyroid gland: a new case of leiomyoma and literature review. Clin Med Insights Oncol. 2018; 12:1179554918813535. https://doi.org/10.1177/1179554918813535
36. Canu GL, Bulla JS, Lai ML, et al. Primary thyroid leiomyosarcoma: a case report and review of the literature. G Chir. 2018; 39(1):51-56. https://doi.org/10.11138/gchir/2018.39.1.051
37. Miettinen M. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis. Mod Pathol. 2014; 27(1 Suppl):S17-29. https://doi.org/10.1038/modpathol.2013.178
38. Kandil E, Abdel Khalek M, Abdullah O, et al. Primary peripheral nerve sheath tumors of the thyroid gland. Thyroid. 2010; 20(6):583-586. https://doi.org/10.1089/thy.2009.0245
39. Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014; 9:rju094. https://doi.org/10.1093/jscr/rju094
40. Miettinen M, McCue PA, Sarlomo-Rikala M, et al. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol. 2015; 39(6):826-835. https://doi.org/10.1097/PAS.0000000000000398
41. Bohlok A, El Khoury M, Bormans A, et al. Schwannoma of the colon and rectum: a systematic literature review. World J Surg Oncol. 2018; 16(1):125-136. https://doi.org/10.1186/s12957-018-1427-1
42. Ghasemi-Rad M, Wang KY, Jain S, Lincoln CM. Solitary fibrous tumor of thyroid: a case report with review of literature. Clin Imaging. 2019; 53:105-107. https://doi.org/10.1016/j.clinimag.2018.09.011
43. Baldi GG, Stacchiotti S, Mauro V, et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013; 3:4. https://doi.org/10.1186/2045-3329-3-4
44. Colia V, Provenzano S, Morosi C, et al. Solitary fibrous tumour presenting with a single bone metastasis: report of six cases and literature review. Clin Sarcoma Res. 2016; 6(1):16. https://doi.org/10.1186/s13569-016-0055-1
45. Demicco EG, Park MS, Araujo DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012; 25(9):1298-1306. https://doi.org/10.1038/modpathol.2012.83
46. Salas S, Resseguier N, Blay JY, et al. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol. 2017; 28(8):1979-1987. https://doi.org/10.1093/annonc/mdx250
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.